Drug-Induced Sweet’s Syndrome by Xcopri

• Published in: Skin (Milwood, N.Y.) N.Y.), 2024-07, Vol.8 (4), p.1728-1731
• Main Authors: Wong, Summer, Kowalczyk, Chris, Karim, Rehan, Skopit, Stanley, Kerdel, Francisco
• Format: Article
• Language: English
• ISSN: 2574-1624; 2574-1624
• DOI: 10.25251/skin.8.4.15

Background: Sweet's syndrome (SS) is a relatively rare, self-limiting dermatological condition predominantly affecting women aged 30-50. It is characterized by the sudden onset of erythematous plaques, nodules, or papules on the skin and is often accompanied by fever, leukocytosis, and systemic symptoms. While most SS cases are idiopathic, approximately 5% are drug-induced. Case: This case report describes a 34-year-old female with a medical history significant for epilepsy who presented with diffuse erythematous papules on the bilateral upper extremities. The onset of these symptoms coincided with the initiation of Xcopri (cenobamate tablets) in her medication regimen. Conclusion: To our knowledge, this report highlights the first case of Xcopri-induced SS. We interpret this patient's presentation as a cutaneous response secondary to an adverse drug reaction and aim to emphasize the importance of obtaining a thorough medication history at each clinical consultation.